{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:40:40Z","timestamp":1790628040175,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2018R1C1B6008884"],"award-info":[{"award-number":["NRF-2018R1C1B6008884"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR18C0016"],"award-info":[{"award-number":["HR18C0016"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2022IP0020"],"award-info":[{"award-number":["2022IP0020"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is unclear whether serum proteins can serve as biomarkers to reflect pathological changes and predict recovery in inflammation of optic nerve. We evaluated whether serum proteins could monitor and prognosticate optic neuritis (ON). We prospectively recruited consecutive patients with recent ON, classified as ON with anti-aquaporin-4 antibody (AQP4-ON), ON with anti-myelin oligodendrocyte glycoprotein antibody (MOG-ON), and double-seronegative ON (DSN-ON). Using ultrasensitive single-molecule array assays, we measured serum neurofilament light chain and glial fibrillary acidic protein (GFAP), and brain-derived neurotrophic factor (BDNF). We analyzed the markers according to disease group, state, severity, and prognosis. We enrolled 60 patients with recent ON (15 AQP4-ON; 14 MOG-ON; 31 DSN-ON). At baseline, AQP4-ON group had significantly higher serum GFAP levels than did other groups. In AQP4-ON group, serum GFAP levels were significantly higher in the attack state than in the remission state and correlated with poor visual acuity. As a prognostic indicator, serum BDNF levels were positively correlated with follow-up visual function in the AQP4-ON group (<jats:italic>r<\/jats:italic>\u2009=\u20090.726,<jats:italic>p<\/jats:italic>\u2009=\u20090.027). Serum GFAP reflected disease status and severity, while serum BDNF was identified as a prognostic biomarker in AQP4-ON. Serum biomarkers are potentially helpful for patients with ON, particularly those with AQP4-ON.<\/jats:p>","DOI":"10.1038\/s41598-023-32748-5","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:05:39Z","timestamp":1680714339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum proteins for monitoring and predicting visual function in patients with recent optic neuritis"],"prefix":"10.1038","volume":"13","author":[{"given":"Hyo Jae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yeob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Taek","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Kuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"32748_CR1","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(02)11919-2","volume":"360","author":"S Hickman","year":"2002","unstructured":"Hickman, S., Dalton, C., Miller, D. & Plant, G. Management of acute optic neuritis. Lancet 360, 1953\u20131962 (2002).","journal-title":"Lancet"},{"key":"32748_CR2","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello, M. et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70, 2197\u20132200 (2008).","journal-title":"Neurology"},{"key":"32748_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","volume":"195","author":"JJ Chen","year":"2018","unstructured":"Chen, J. J. et al. Myelin oligodendrocyte glycoprotein antibody\u2013positive optic neuritis: Clinical characteristics, radiologic clues, and outcome. Am. J. Ophthal. 195, 8\u201315 (2018).","journal-title":"Am. J. Ophthal."},{"key":"32748_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato, D. K. et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82, 474\u2013481 (2014).","journal-title":"Neurology"},{"key":"32748_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy, A. T., Mason, D. F. & Miller, D. H. Optic neuritis. Lancet Neurol. 13, 83\u201399 (2014).","journal-title":"Lancet Neurol."},{"key":"32748_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos, M. C. & Verkman, A. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 11, 535\u2013544 (2012).","journal-title":"Lancet Neurol."},{"key":"32748_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl, M. & Waters, P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat. Rev. Neurol. 15, 89\u2013102 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"32748_CR8","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk, M. et al. Clinical presentation and prognosis in MOG-antibody disease: A UK study. Brain 140, 3128\u20133138 (2017).","journal-title":"Brain"},{"key":"32748_CR9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","volume":"69","author":"MA Mealy","year":"2012","unstructured":"Mealy, M. A., Wingerchuk, D. M., Greenberg, B. M. & Levy, M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis. Arch. Neurol. 69, 1176\u20131180 (2012).","journal-title":"Arch. Neurol."},{"key":"32748_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","volume":"137","author":"ONS Group","year":"2004","unstructured":"Group, O. N. S. Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial. Am. J. Ophthal. 137, 77\u201383 (2004).","journal-title":"Am. J. Ophthal."},{"key":"32748_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595 (2010).","journal-title":"Nat. Biotechnol."},{"key":"32748_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577\u2013589 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"32748_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto, G. et al. Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann. Neurol. 81, 857\u2013870 (2017).","journal-title":"Ann. Neurol."},{"key":"32748_CR14","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","volume":"93","author":"M Watanabe","year":"2019","unstructured":"Watanabe, M. et al. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 93, e1299\u2013e1311 (2019).","journal-title":"Neurology"},{"key":"32748_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K. & Initiative, A. D. N. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 74, 557\u2013566 (2017).","journal-title":"JAMA Neurol."},{"key":"32748_CR16","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen, K. et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88, 2302\u20132309 (2017).","journal-title":"Neurology"},{"key":"32748_CR17","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.0000000000004645","volume":"89","author":"T Gattringer","year":"2017","unstructured":"Gattringer, T. et al. Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology 89, 2108\u20132114 (2017).","journal-title":"Neurology"},{"key":"32748_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/ana.26067","volume":"89","author":"O Aktas","year":"2021","unstructured":"Aktas, O. et al. Serum glial fibrillary acidic protein: A neuromyelitis optica spectrum disorder biomarker. Ann. Neurol. 89, 895\u2013910 (2021).","journal-title":"Ann. Neurol."},{"key":"32748_CR19","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/brain\/awq179","volume":"133","author":"RA Linker","year":"2010","unstructured":"Linker, R. A. et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: Therapeutic implications in a model of multiple sclerosis. Brain 133, 2248\u20132263 (2010).","journal-title":"Brain"},{"key":"32748_CR20","doi-asserted-by":"publisher","first-page":"14182","DOI":"10.1523\/JNEUROSCI.6595-10.2011","volume":"31","author":"MW VonDran","year":"2011","unstructured":"VonDran, M. W., Singh, H., Honeywell, J. Z. & Dreyfus, C. F. Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J. Neurosci. 31, 14182\u201314190 (2011).","journal-title":"J. Neurosci."},{"key":"32748_CR21","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","volume":"34","author":"CG Fulmer","year":"2014","unstructured":"Fulmer, C. G. et al. Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. J. Neurosci. 34, 8186\u20138196 (2014).","journal-title":"J. Neurosci."},{"key":"32748_CR22","doi-asserted-by":"publisher","first-page":"14002","DOI":"10.1523\/JNEUROSCI.1592-15.2015","volume":"35","author":"N Miyamoto","year":"2015","unstructured":"Miyamoto, N. et al. Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor. J. Neurosci. 35, 14002\u201314008 (2015).","journal-title":"J. Neurosci."},{"key":"32748_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"32748_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold, A. & Plant, G. T. Chronic relapsing inflammatory optic neuropathy: A systematic review of 122 cases reported. J. Neurol. 261, 17\u201326 (2014).","journal-title":"J. Neurol."},{"key":"32748_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/wnl.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177\u2013189. https:\/\/doi.org\/10.1212\/wnl.0000000000001729 (2015).","journal-title":"Neurology"},{"key":"32748_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang, Z. & Wang, K. K. Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 38, 364\u2013374 (2015).","journal-title":"Trends Neurosci."},{"key":"32748_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen, S. et al. Specialized membrane domains for water transport in glial cells: High-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17, 171\u2013180 (1997).","journal-title":"J. Neurosci."},{"key":"32748_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jocn.2020.11.016","volume":"83","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders. J. Clin. Neurosci. 83, 108\u2013111 (2021).","journal-title":"J. Clin. Neurosci."},{"key":"32748_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/jnnp-2018-320287","volume":"90","author":"S Mariotto","year":"2019","unstructured":"Mariotto, S. et al. Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders. J. Neurol. Neurosurg. Psychiatry 90, 1293\u20131296 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"32748_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211024978","author":"H Kim","year":"2021","unstructured":"Kim, H. et al. Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder. Mult. Scler. J. https:\/\/doi.org\/10.1177\/13524585211024978 (2021).","journal-title":"Mult. Scler. J."},{"key":"32748_CR31","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1212\/NXI.0000000000000708","volume":"7","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. Serum biomarkers in myelin oligodendrocyte glycoprotein antibody\u2013associated disease. Neurol. Neuroimmunol. Neuroinflamm. 7, e708 (2020).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"32748_CR32","doi-asserted-by":"publisher","first-page":"e23489","DOI":"10.1371\/journal.pone.0023489","volume":"6","author":"M Storoni","year":"2011","unstructured":"Storoni, M., Petzold, A. & Plant, G. T. The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis. PLoS ONE 6, e23489 (2011).","journal-title":"PLoS ONE"},{"key":"32748_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2012.02.012","volume":"317","author":"M Storoni","year":"2012","unstructured":"Storoni, M. et al. Serum GFAP levels in optic neuropathies. J. Neurol. Sci. 317, 117\u2013122 (2012).","journal-title":"J. Neurol. Sci."},{"key":"32748_CR34","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/acn3.51070","volume":"7","author":"EJ Lee","year":"2020","unstructured":"Lee, E. J. et al. Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases. Ann. Clin. Transl. Neurol. 7, 992\u20131001 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"32748_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.540156","author":"AG Filippatou","year":"2020","unstructured":"Filippatou, A. G., Mukharesh, L., Saidha, S., Calabresi, P. A. & Sotirchos, E. S. AQP4-IgG and MOG-IgG related optic neuritis\u2014Prevalence, optical coherence tomography findings, and visual outcomes: A systematic review and meta-analysis. Front. Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.540156 (2020).","journal-title":"Front. Neurol."},{"key":"32748_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2022.866824","volume":"13","author":"A Dinoto","year":"2022","unstructured":"Dinoto, A. et al. Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease. Front. Neurol. 13, 1\u201313 (2022).","journal-title":"Front. Neurol."},{"key":"32748_CR37","first-page":"1","volume":"3","author":"S Mariotto","year":"2017","unstructured":"Mariotto, S. et al. Serum neurofilament light chain in NMOSD and related disorders: Comparison according to aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies status. Mult. Scler. J. Exp. Transl. Clin. 3, 1\u20134 (2017).","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"32748_CR38","doi-asserted-by":"publisher","first-page":"647618","DOI":"10.3389\/fimmu.2021.647618","volume":"12","author":"X Chang","year":"2021","unstructured":"Chang, X. et al. Serum neurofilament light and GFAP are associated with disease severity in inflammatory disorders with aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies. Front. Immunol. 12, 647618 (2021).","journal-title":"Front. Immunol."},{"key":"32748_CR39","doi-asserted-by":"publisher","first-page":"102833","DOI":"10.1016\/j.msard.2021.102833","volume":"50","author":"S Mariotto","year":"2021","unstructured":"Mariotto, S. et al. NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders. Mult. Scler. Relat. Disord. 50, 102833 (2021).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"32748_CR40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/1352458519840757","volume":"26","author":"JW Hyun","year":"2020","unstructured":"Hyun, J. W., Kim, Y., Kim, G., Kim, S. H. & Kim, H. J. Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis. Mult. Scler. 26, 659\u2013667. https:\/\/doi.org\/10.1177\/1352458519840757 (2020).","journal-title":"Mult. Scler."},{"key":"32748_CR41","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0331-16.2016","author":"L Feng","year":"2017","unstructured":"Feng, L. et al. Overexpression of brain-derived neurotrophic factor protects large retinal ganglion cells after optic nerve crush in mice. Eneuro https:\/\/doi.org\/10.1523\/ENEURO.0331-16.2016 (2017).","journal-title":"Eneuro"},{"key":"32748_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","volume":"19","author":"L Gr","year":"1996","unstructured":"Gr, L. & Barde, Y. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19, 289\u2013317 (1996).","journal-title":"Annu. Rev. Neurosci."},{"key":"32748_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/brain\/awf015","volume":"125","author":"C Stadelmann","year":"2002","unstructured":"Stadelmann, C. et al. BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?. Brain 125, 75\u201385 (2002).","journal-title":"Brain"},{"key":"32748_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tins.2020.05.006","volume":"43","author":"KS Rawji","year":"2020","unstructured":"Rawji, K. S., Martinez, G. A. G., Sharma, A. & Franklin, R. J. The role of astrocytes in remyelination. Trends Neurosci. 43, 596\u2013607 (2020).","journal-title":"Trends Neurosci."},{"key":"32748_CR45","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3389\/fimmu.2020.573256","volume":"11","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer, M. & Rothhammer, V. Protective functions of reactive astrocytes following central nervous system insult. Front. Immunol. 11, 2571 (2020).","journal-title":"Front. Immunol."},{"key":"32748_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","volume":"26","author":"M Lommatzsch","year":"2005","unstructured":"Lommatzsch, M. et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26, 115\u2013123 (2005).","journal-title":"Neurobiol. Aging"},{"key":"32748_CR47","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1212\/WNL.0000000000009985","volume":"95","author":"P Shahim","year":"2020","unstructured":"Shahim, P. et al. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Neurology 95, e623\u2013e636 (2020).","journal-title":"Neurology"},{"key":"32748_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1352458518819380","volume":"26","author":"H H\u00f6gel","year":"2020","unstructured":"H\u00f6gel, H. et al. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. Mult. Scler. J. 26, 210\u2013219 (2020).","journal-title":"Mult. Scler. J."},{"key":"32748_CR49","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"Costello, F. et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann. Neurol. 59, 963\u2013969 (2006).","journal-title":"Ann. Neurol."},{"key":"32748_CR50","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"J Ratchford","year":"2009","unstructured":"Ratchford, J. et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73, 302\u2013308 (2009).","journal-title":"Neurology"},{"key":"32748_CR51","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"P Waters","year":"2012","unstructured":"Waters, P. et al. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neurology 78, 665\u2013671 (2012).","journal-title":"Neurology"},{"key":"32748_CR52","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","volume":"92","author":"PJ Waters","year":"2019","unstructured":"Waters, P. J. et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology 92, e1250\u2013e1255 (2019).","journal-title":"Neurology"},{"key":"32748_CR53","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle, J. et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92, e1007\u2013e1015 (2019).","journal-title":"Neurology"},{"key":"32748_CR54","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"C Teunissen","year":"2009","unstructured":"Teunissen, C. et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73, 1914\u20131922 (2009).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32748-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32748-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T07:19:40Z","timestamp":1702192780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32748-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32748-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5609"}}